ProKidney Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.89	0.89	0.08	-	-	-
Revenue Growth	190.52%	1075.00%	-	-	-	-
Gross Profit	0.89	0.89	0.08	-	-	-
Selling, General & Admin	48.74	51.78	56.08	44.82	70.94	8.86
Research & Development	120.7	114.12	127.67	106.71	82.07	46.26
Total Operating Expenses	169.44	165.9	183.75	151.52	153.01	55.11
Operating Income	-168.55	-165.01	-183.68	-151.52	-153.01	-55.11
Interest Income	12.11	13.81	19.75	22.08	5.98	0
Interest Expense	-0.02	-0	-0.01	-0.01	-0.22	-
Total Non-Operating Income (Expense)	12.09	13.81	19.74	22.07	5.77	0
Pretax Income	-156.46	-151.2	-163.93	-129.45	-147.24	-55.11
Provision for Income Taxes	1.41	0.41	-0.6	6	0.9	0.04
Net Income	-156.28	-151.61	-163.34	-135.45	-148.14	-55.15
Minority Interest in Earnings	-83.99	-82.63	-102.15	-99.98	-40.1	-
Net Income to Common	-72.29	-68.99	-61.19	-35.47	-108.03	-55.15
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	137	134	98	62	62	151
Shares Outstanding (Diluted)	137	134	98	62	62	151
Shares Change	19.98%	36.79%	58.66%	0.28%	-59.17%	40.85%
EPS (Basic)	-0.53	-0.52	-0.62	-0.57	-0.23	-0.37
EPS (Diluted)	-0.53	-0.52	-0.62	-0.57	-0.23	-0.37
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-150.06	-135.31	-155.86	-124.27	-78.94	-55.49
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-1.09	-1.01	-1.59	-2.01	-1.28	-0.37
Gross Margin	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-18959.70%	-18477.80%	-241679.00%	-	-	-
Profit Margin	-17579.40%	-16977.80%	-214914.00%	-	-	-
FCF Margin	-16879.10%	-15152.60%	-205079.00%	-	-	-
EBITDA	-161.92	-158.43	-178.24	-147.67	-149.97	-53.13
EBITDA Margin	-18213.60%	-17741.50%	-234532.00%	-	-	-
EBIT	-168.55	-165.01	-183.68	-151.52	-153.01	-55.11
EBIT Margin	-18959.70%	-18477.80%	-241679.00%	-	-	-
Effective Tax Rate	-0.90%	-0.27%	0.36%	-4.63%	-0.61%	-0.07%

SEC Filings: 10-K · 10-Q